Related Experiment Video
Updated: Jan 17, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Polyglycerol-Based Lipids: A Next-Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery
Yara Ensminger1, Rashmi Rashmi1, Michael Karimov2
1Institute For Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Linear polyglycerol (lPG) offers an alternative to polyethylene glycol (PEG) in lipid nanoparticles (LNPs) for mRNA delivery. lPG-functionalized LNPs avoid anti-PEG antibodies, maintaining transfection efficiency comparable to PEGylated systems.
Area of Science:
- Biotechnology
- Nanomedicine
- Polymer Chemistry
Background:
- Polyethylene glycol (PEG) is a common polymer used in drug delivery systems like lipid nanoparticles (LNPs) to evade the immune system, providing a 'stealth' effect.
- However, the rising prevalence of anti-PEG antibodies in patients can trigger adverse immune responses and rapid clearance of PEGylated therapeutics, limiting their effectiveness.
- Lipid nanoparticles (LNPs) are crucial for delivering nucleic acids, with significant therapeutic potential demonstrated by mRNA vaccines.
Purpose of the Study:
- To develop and evaluate linear polyglycerol (lPG) as a non-immunogenic stealth polymer alternative to PEG in LNPs.
- To assess the ability of lPG-functionalized LNPs to deliver mRNA while avoiding immune reactions associated with anti-PEG antibodies.
- To compare the mRNA transfection efficiency of lPG-LNPs with traditional PEG-LNPs.
Main Methods:
- Formulation of lipid nanoparticles (LNPs) incorporating linear polyglycerol (lPG) as a surface coating.
- Evaluation of the binding affinity of lPG-functionalized LNPs to IgG anti-PEG antibodies.
- Assessment of mRNA (eGFP) delivery and transfection efficiency in HepG2 cells using lPG-LNPs compared to PEG-LNPs.
Main Results:
- lPG-functionalized LNPs exhibited negligible binding to IgG anti-PEG antibodies, indicating reduced immunogenicity.
- Successful delivery of enhanced green fluorescent protein (eGFP) mRNA into HepG2 cells was achieved using lPG-LNPs.
- The mRNA transfection efficiency of lPG-LNPs was comparable to that of PEGylated LNPs.
Conclusions:
- Linear polyglycerol (lPG) serves as a viable alternative to polyethylene glycol (PEG) in LNP formulations for mRNA delivery.
- lPG-functionalization of LNPs effectively mitigates immune responses related to anti-PEG antibodies.
- lPG-based LNPs demonstrate promising potential for safe and efficient nucleic acid delivery in therapeutic applications.
More Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...

